medigraphic.com
ISSN 1561-3194 (Electronic)

2022, Number 1

<< Back Next >>

Rev Ciencias Médicas 2022; 26 (1)

Clinical and epidemiological characteristics of testicular cancer and its therapeutic management

Díaz-Dueñas Y, Zayas-Veliz R, Hernández-Campo PR, Amaran-Valvarde JE, Suarez-Alfonso OE

Language: Spanish
References: 20
Page: 1-9
PDF size: 386.33 Kb.


ABSTRACT

Introduction: among the neoplasms affecting males, testicular germ cell tumors account for 0,5-1 %. In the last four decades there has been an increase in the incidence of testicular cancer from 5,7 to 6,8 cases per 100,000 inhabitants.
Objective: to characterize the epidemiological clinical behavior and therapeutic management of patients with testicular cancer in Pinar del Rio from 2010 to 2019.
Methods: an observational, descriptive, retrospective study was carried out in Pinar del Río province from 2010 to 2019 which comprised the total number of patients diagnosed and treated for testicular cancer registered in the Cancer Care Center (III Congress). A data base was made where qualitative variables were expressed in absolute frequencies and relative frequencies in percentages.
Results: ages between 31 and 40 predominated (29,5 %) and white race (94,1 %); the most frequent reason for consultation was testicular enlargement (70,6 %). Histologically, seminoma predominated (58,8 %), with predominance of clinical stages IA and IB. There was a stable disease response in 41,2 %.
Conclusions: testicular tumors occurred more frequently in the fourth decade of life attending consultation for testicular enlargement; the most frequent histological type were seminomas in clinical stages IA and IB and in most of them there was a stable response of the disease.


REFERENCES

  1. Notario Barba V, Carbayo García JJ, Magallanes Gamboa JO. Tumoración testicular. Rev Clin Med Farm [Internet]. 2016 [citado: 03/06/2021]; 9(2): 131-134. Disponible en: Disponible en: https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1699-695X2016000200013

  2. Savón Moiran L, Viel Reyes H, Guilarte Harriete M. Generalidades sobre cáncer de testículo. Rev Inf Cient [Internet]. 2015 [citado: 03/06/2021]; 91(3): 565-576. Disponible en: Disponible en: http://www.revinfcientifica.sld.cu/index.php/ric/article/view/234

  3. Garolla A, De Toni L, Bottacin A, Valente U, De Rocco Ponce M, Di Nisio A, et al. Human papillomavirus prophylactic vaccination improves reproductive outcome in infertile patients with HPV semen infection: a retrospective study. Sci Rep [Internet]. 2018 [citado: 11/02/2020]; 8(912). Disponible en: Disponible en: https://www.nature.com/articles/s41598-018-19369-z

  4. Boccellino M, Vanacore D, Zappavigna S, Cavaliere C, Rossetti S, D'Aniello C, et al. Testicular cancer from diagnosis to epigenetic factors. Oncotarget [Internet]. 2017 [citado: 03/06/2021]; 8(61): 104654-104663. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/29262668/

  5. Williamson SR, Delahunt B, Magi-Galluzzi C, Algaba F, Egevad L, Ulbright TM, et al. Members of the ISUP testicular tumour panel. The World Health Organization 2016 classification of testicular germ cell tumours: A review and update from the International Society of Urological Pathology Testis Consultation Panel. Histopathology [Internet]. 2017 [citado: 11/02/2020]; 70(3): 335-346. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/27747907/

  6. Gurolla A, Vitagliano A, Muscianisi F, Valente U, Ghezzi M, Andrisani A, et al. Role of Viral Infections in Testicular Cancer Etiology: Evidence From a Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne) [Internet]. 2019 [citado: 03/06/2020]; 10: 355. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584824/

  7. Rodríguez Moreno JF. Cáncer de testículo [Internet]. SEOM. Madrid; 2020 [citado: 14/01/2020]. Disponible en: Disponible en: https://seom.org/info-sobre-el-cancer/testiculo?start=0

  8. Grande G, Milardi D, Martini M, Cenci T, Gulino G, Mancini F, et al. Protein Expression of PTTG-1, OCT-4, and KLF-4 in Seminoma: A Pilot Study. Front Endocrinol (Lausanne) [Internet]. 2019 [citado: 03/06/2020]; 10: 619. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/31572301/

  9. Zachary L. Testicular Cancer Epidemiology, Diagnosis, and Management. Med Clin N Am [Internet]. 2018 [citado:03/06/2020]; 102(2): 251-264. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/29406056/

  10. Cuba, Ministerio de Salud Pública. Anuario estadístico [Internet].La Habana: MINSAP; 2018. [citado: 03/06/2020] Disponible en: Disponible en: https://salud.msp.gob.cu/portfolio/anuario-estadistico/

  11. INSTITUTO NACIONAL DE ONCOLOGÍA. TRATAMIENTO DEL Cáncer de testículo [INTERNET]. NIH; 2018. [CITADO: 03/06/2020]. DISPONIBLE EN: DISPONIBLE EN: HTTPS://WWW.CANCER.GOV/ESPANOL/TIPOS/TESTICULO/PRO/TRATAMIENTO-TESTICULO-PDQ

  12. Reginelli A, D'Andrea A, Clemente A, Izzo A, Urraro F, Scala F, et al. Does multiparametric US improve diagnostic accuracy in the characterization of small testicular masses? Gland Surg [Internet]. 2019 [citado: 23/09/2020]; 8(3): 136-41. Disponible en: Disponible en: https://gs.amegroups.com/article/view/25117/25403

  13. Palumbo C, Mistretta FA, Mazzone E, Knipper S, Tian Z, Perrotte P, et al. Contemporary Incidence and Mortality Rates in Patients With Testicular Germ Cell Tumors. Clin Genito urin Cancer [Internet]. 2019 [citado: 29/03/2020]; 17(5): 1026-35. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/31378580/

  14. Nason GJ, Leao R, Hamilton RJ. Active surveillance in stage 1 disease: standard of care independent of risk factors? CurrOpinUrol [Internet]. 2020 [citado: 12/09/2020]; 30(2):245-50. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/31834082/

  15. Gurrola Ortega A, Sánchez Núñez JE, Rivera Astorga H, Magaña González JE, Sarabia Estrada RC, Garduño Arteaga LM, et al. Cáncer testicular: incidencia, epidemiología y etiología. Cinco años de experiencia en el Hospital General de México Dr. Eduardo Liceaga. Rev Mex Urol [Internet]. 2018 [citado: 12/09/2020]; 78(5): 347-53. Disponible en: Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=83278

  16. Oosterhuis JW, Looijenga LHJ. Human germ cell tumours from a developmental perspective. Nat Rev Cancer [Internet]. 2019 [citado: 09/12/2020]; 19(9): 522-37. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/31413324/

  17. Cullen M, Huddart R, Joffe J, Gardiner D, Maynard L, Hutton P, et al. The 111 Study: A Single-arm, Phase 3 Trial Evaluating One Cycle of Bleomycin, Etoposide, and Cisplatin as Adjuvant Chemotherapy in High-risk, Stage 1 Nonseminomatous or Combined Germ Cell Tumours of the Testis. Eur Urol [Internet]. 2020 [citado: 03/06/2020]; 77(3):344-351. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/31901440/

  18. Aparicio J, Sánchez Muñoz A, Ochenduszko S, Gumà J, Fernández Aramburo A, García Del Muro X, et al. Treatment and Outcome of Patients with Stage IS Testicular Cancer: A Retrospective Study from the Spanish Germ Cell Cancer Group. J Urol [Internet]. 2019 [citado: 05/08/2020]; 202(4): 742-7. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/31163007/

  19. Tremeau L, Mottet N. Management of residual masses of testis germ cell tumors. Bull Cancer [Internet]. 2020 [citado: 11/02/2021]; 107(2): 215-223. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/31882267/

  20. Fontes-Sousa M, Lobo J, Magalhães H, et al. Clinical implications of the American Joint Committee on Cancer (AJCC) 8th edition update in seminoma pT1 subclassification. BMC Urol [Internet]. 2020 [citado:20/4/2021]; 20(127). Disponible en: Disponible en: https://bmcurol.biomedcentral.com/articles/10.1186/s12894-020-00682-7




2020     |     www.medigraphic.com